Vitalhub (VHI) Planet MicroCap Showcase: VEGAS 2025 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase: VEGAS 2025 summary
27 Dec, 2025Company overview and market focus
Specializes in healthcare IT software, with over 50 solutions targeting government-funded healthcare systems outside the U.S., operating in Canada, the U.K., Australia, and the Middle East.
Growth achieved through both organic means and 22 acquisitions, reaching over $70 million in annual recurring revenue (ARR).
Focuses on consolidating niche vendors to create a stronger, cohesive offering in a $10 billion non-U.S. healthcare IT market.
Product and solution portfolio
Main offerings include patient flow and operational visibility solutions, helping healthcare organizations manage patient movement and capacity.
Patient engagement products assist individuals with navigation, scheduling, and aftercare within healthcare systems.
Electronic records for social services and care coordination, primarily in Canada, serve large organizations and entire provinces.
Workforce automation solutions, mainly in the U.K., support compliance, recruiting, and certification for healthcare staff.
M&A and operational strategy
Acquisitions target companies with $2–$20 million in revenue, focusing on those with at least 60% recurring revenue.
Typical acquisition multiples range from 1x to 2.5x revenue, with some exceptions above 3x.
Integration strategy includes consolidating G&A, leveraging a 200+ person Sri Lankan R&D team for cost-effective innovation.
Cross-selling and operational synergies drive organic ARR growth, averaging $1.5 million per quarter.
Latest events from Vitalhub
- ARR hit CAD 101.5M, revenue rose 33%, and margins improved with a major European acquisition.VHI
Q2 2026 - ARR and revenue surged year-over-year, margins improved, and cash reserves strengthened.VHI
Q1 2026 - ARR and revenue surged in 2025, with strong EBITDA margin and cash for acquisitions.VHI
Q4 2025 - Growth through acquisitions and AI integration aims to boost recurring revenue and margins by 2026.VHI
2nd Annual Lytham Partners Healthcare Investor Summit - Delivers $93.7M ARR and 22% EBITDA margin through global healthcare software and M&A.VHI
Investor presentation - Q3 revenue and ARR up 25%, pro forma ARR hits CAD 68M after acquisitions, cash at CAD 81.4M.VHI
Q3 2024 - Q2 revenue up 24% YoY, ARR up 25%, and adjusted EBITDA margin reached 26% on strong recurring growth.VHI
Q2 2024 - ARR up 54% and revenue up 42%, with CAD 91.2M cash fueling strong M&A activity.VHI
Q1 2025 - ARR up 59% to CAD 71.1m, record Q4 revenue, strong cash, and continued M&A focus.VHI
Q4 2024